BOUDREAUX GAIL

Insider profile

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
BOUDREAUX GAIL's trades of Elevance Health Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-07-18 2025-07-18 B Purchase
89,866 -11.8%
388.19
US$4,506,355
89,866 -11.8% 388.19 US$4,506,355
2025-07-18 2025-07-18 B Purchase
29,147 -45.7%
168.69
US$1,869,340
29,147 -45.7% 168.69 US$1,869,340
2025-07-18 2025-07-18 B Purchase
79,904 +5.3%
99.73
US$2,608,948
79,904 +5.3% 99.73 US$2,608,948
2024-07-23 2024-07-22 PlS Planned sale
2,250 -1.7%
504.27
US$1,134,608
2,250 -1.7% 504.27 US$1,134,608
2024-07-23 2024-07-22 PlS Planned sale
1,000 -0.8%
503.67
US$503,670
1,000 -0.8% 503.67 US$503,670
2024-07-23 2024-07-22 PlS Planned sale
2,250 -1.7%
502.23
US$1,130,018
2,250 -1.7% 502.23 US$1,130,018
2024-07-23 2024-07-22 PlS Planned sale
6,621 -4.8%
501.40
US$3,319,769
6,621 -4.8% 501.40 US$3,319,769
2024-07-23 2024-07-22 PlS Planned sale
20,779 -13.0%
500.36
US$10,396,980
20,779 -13.0% 500.36 US$10,396,980
2024-07-23 2024-07-22 PlS Planned sale
1,100 -0.7%
498.50
US$548,350
1,100 -0.7% 498.50 US$548,350
2024-07-22 2024-07-22 PrS Proposed sale
34,000
500.98
US$17,033,398
34,000 500.98 US$17,033,398
2020-01-31 2020-01-30 B Purchase
2,000 +8.1%
264.22
US$528,440
2,000 +8.1% 264.22 US$528,440
2020-01-31 2020-01-30 B Purchase
5,600 +29.5%
263.52
US$1,475,712
5,600 +29.5% 263.52 US$1,475,712
2019-02-06 2019-02-05 B Purchase
2,095 +inf%
119.33
US$249,988
2,095 +inf% 119.33 US$249,988